Clinical trials in Mansfield, TX

20 recruiting studies have a site in or near Mansfield, TX, Texas.

Top conditions here

All conditions

Showing 20 of 20 studies

RecruitingPhase 3NCT06819878

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Hoffmann-La Roche

Arlington, TX · El Paso, TX · Georgetown, TX · +92 more sites

RecruitingPhase 3NCT06617325

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sponsor: UCB Biopharma SRL

Bellaire, TX · El Paso, TX · Fort Worth, TX · +60 more sites

RecruitingPhase 2NCT07697456

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Sponsor: AbbVie

Bellaire, TX · Fort Worth, TX · Garland, TX · +57 more sites

RecruitingPhase 3NCT06307652

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Sponsor: AstraZeneca

Allen, TX · Amarillo, TX · +163 more sites

RecruitingPhase 3NCT06430801

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Sponsor: Merck Sharp & Dohme LLC

Dallas, TX · Denton, TX · +84 more sites

RecruitingPhase 2NCT06226883

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

Cedar Park, TX · Denton, TX · Houston, TX · +22 more sites

RecruitingPhase 2NCT07415044

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Sponsor: Eli Lilly and Company

Fort Worth, TX · Garland, TX · Houston, TX · +49 more sites

RecruitingPhase 2NCT07845487

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Palisade Bio

Garland, TX · Georgetown, TX · Houston, TX · +27 more sites

RecruitingPhase 2NCT06233461

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Takeda

Bellaire, TX · Dallas, TX · Fort Worth, TX · +27 more sites

RecruitingPhase 2NCT06548542

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Sponsor: AbbVie

Cedar Park, TX · El Paso, TX · Garland, TX · +61 more sites

RecruitingPhase 2NCT06343298

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension

Sponsor: E-Star BioTech, LLC

Coppell, TX · Dallas, TX · Denton, TX · +20 more sites

RecruitingPhase 4NCT06095128

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Sponsor: Takeda

Dallas, TX · Houston, TX · Mansfield, TX · +34 more sites

RecruitingPhase 3NCT06677060

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Sponsor: AstraZeneca

Abilene, TX · Austin, TX · Beaumont, TX · +195 more sites

RecruitingPhase 3NCT05125302

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Sponsor: AbbVie

Austin, TX · +122 more sites

RecruitingPhase 4NCT06045754

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Sponsor: Takeda

Cedar Park, TX · Dallas, TX · Houston, TX · +38 more sites

RecruitingPhase 2NCT07082738

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sponsor: AstraZeneca

Boerne, TX · Dallas, TX · Denison, TX · +83 more sites

RecruitingPhase 3NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Sponsor: AstraZeneca

Dallas, TX · Forney, TX · Fort Worth, TX · +70 more sites

RecruitingPhase 3NCT04777357

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Sponsor: AbbVie

Austin, TX · Beaumont, TX · Bellaire, TX · +66 more sites

RecruitingNot applicableNCT07659821

Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies

Sponsor: Texas A&M University

College Station, TX · Dallas, TX · Mansfield, TX

RecruitingPhase 2NCT06456593

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Sponsor: Abivax S.A.

Austin, TX · Baytown, TX · Bellaire, TX · +40 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.